REFERENCE

EBITDA multiples in home care, home health, and hospice

An EBITDA multiple is simply the price a buyer pays divided by adjusted annual earnings. In home care, home health, and hospice, the multiple a specific agency earns depends far more on size, payer quality, and owner dependence than on the segment average. Anyone who quotes you a single number without seeing your financials is guessing.

Akim Guennani

By Akim Guennani, Founder · Updated September 2026

8.5x

2025 healthcare services average EV / EBITDA

6.0x

2025 average for $10M to $25M enterprise values

229

US mid-market healthcare deals in Q4 2025

Why size moves the multiple so much

Buyers price risk. An agency with a few hundred thousand dollars of EBITDA is usually one owner, a handful of referral relationships, and limited infrastructure, so a departure or a rate change is material. A platform with several million dollars of EBITDA has management depth, multiple sites, and diversified payers, so the same shock is absorbed.

This is why consolidation works, and why rollover equity is attractive: an owner who rolls a stake into a larger platform can see that stake revalued at the platform multiple in the next transaction.

What pulls an agency into a higher band

These are the changes that most reliably improve the multiple, and most can be started a year before any sale.

Management depth
A director who runs operations without you makes the business transferable.
Payer and referral diversification
No single source above roughly 20 to 25 percent of revenue.
Clean financial reporting
Accrual accounting, monthly close, and a defensible EBITDA adjustment schedule.
Documented compliance
Current licenses, accreditation, exclusion screening, and clean survey history.
Demonstrated growth
Census, admissions, or visit growth over the trailing two years.

What a multiple does not tell you

A high multiple attached to a large earnout, a long commitment period, and a punishing working capital peg can be worth less than a lower multiple paid mostly in cash. Compare total expected proceeds, the probability of each contingent component, and what your life looks like after closing.

What EBITDA multiples represent

An EBITDA multiple is a shorthand way to describe the value of a business relative to its annual cash flow. Across all healthcare services transactions, MNP reported an average EV/EBITDA multiple of 8.5x in 2025. In the lower mid-market ($10 million to $25 million of enterprise value) the average was 6.0x, down from 6.8x in 2024. This number represents the 'Enterprise Value' divided by the 'Adjusted EBITDA.' It is a reflection of the market's perception of risk and growth potential. Higher multiples are paid for businesses with stable earnings, low risk, and high growth prospects.

For home care agencies, the bands in the table below follow Scope Research's 2025 ranges for personal care and home health and 2026 industry benchmarks for hospice; the next section breaks them out by segment. It is dangerous to assume any average applies to a specific business. A single-location agency and a large, multi-state platform have different scale, liquidity, management, and risk profiles. The multiple is not a static fact; it is a negotiated figure that depends on dozens of variables, including compliance, payer mix, and the current interest rate environment.

RangeTypical home care multipleBusiness CharacteristicsMarket Perception
Lower Range3x to 5x EBITDAHigh turnover, single site, owner-dependentHigher Risk / Lower Growth
Middle Range5x to 8x EBITDAStable staff, multi-site, professional managementModerate Risk / Standard Growth
Upper Range8x to 12x+ EBITDAMulti-state, diversified payers, strong marginsLower Risk / High Growth
Public MarketNot comparableMassive scale, highly liquid (e.g. Addus HomeCare)Non-Comparable to Private

Published multiple ranges by segment and size

Published EBITDA multiple bands for home care, by segment and size. Personal care and home health follow Scope Research's 2025 review of home-based care deals. Personal care (non-medical) agencies trade at about 3x to 5x when small and single-market, 5x to 8x for regional operators, and 7x to 10x for scaled platforms. Medicare-certified home health trades at about 3x to 6x under roughly $5 million of revenue, 6x to 9x for regional multi-branch agencies ($5 million to $25 million of revenue), and 9x to 12x or more for multi-state platforms.

Hospice, per 2026 industry benchmarks, trades at about 4.5x to 6x below $500,000 of EBITDA, 5.5x to 7.5x between $500,000 and $2 million, and 7x to 9x above $2 million. For the smallest deals, Scope's database puts the median at 4.7x EBITDA for home-based care transactions under $10 million of enterprise value, with the middle half between 4.1x and 6.5x. Skilled home health generally prices above personal care at the same EBITDA because the Medicare certification and episodic revenue carry more strategic value.

SegmentSmall, single marketRegional / mid-sizeLarge platform
Personal care (non-medical)3x to 5x5x to 8x7x to 10x
Home health (Medicare-certified)3x to 6x6x to 9x9x to 12x+
Hospice4.5x to 6x5.5x to 7.5x7x to 9x

Adjusting EBITDA for a sale

Most private businesses are managed to minimize taxes, not maximize profit. Before a sale, you must 'normalize' or 'adjust' your EBITDA to show the true earning power of the business. Common adjustments include adding back personal expenses, one-time legal fees, and the portion of the owner's salary that exceeds a market-rate replacement. Without these adjustments, your business will appear less profitable and command a lower valuation.

Buyers will perform their own 'Quality of Earnings' (QofE) analysis to verify these adjustments. They will look for 'debt-like items' such as unfunded PTO or pending legal settlements that could reduce the final price. Public home care companies such as Addus HomeCare operate at a different scale, with cheaper capital and diversified payers, so their trading multiples should not be used as a direct benchmark for a private agency.

Illustrative example: Impact of a Multiple Shift

If an agency has $500,000 in Adjusted EBITDA, a 5x multiple results in a $2.5M value. If the owner improves caregiver retention and diversifies the payer mix, they might earn a 7x multiple. At the same $500,000 EBITDA, the value rises to $3.5M. This $1,000,000 increase in value comes from reducing risk, not necessarily from increasing current earnings.

The role of market conditions

External factors like interest rates and federal policy also affect multiples. When debt is expensive, buyers cannot pay as much for acquisitions because their financing costs are higher. Furthermore, increased regulatory scrutiny, such as the March 2024 federal inquiry into private equity in healthcare, can lead to more cautious bidding. Sellers should be aware that the 'market multiple' can shift quickly based on factors outside their control.

Preparation is the best way to protect your multiple. Having clean, audited financials and a strong management team makes your business a 'flight to quality' asset that can command top dollar even in a difficult market. Always seek specialized financial and legal advice before entering into a transaction, as deal structures and tax implications are complex and varies by situation. This guide is for general informational purposes only.

Sources and methodology

Public transactions provide market context, not a valuation quote for a private practice. Illustrative examples use hypothetical assumptions and are not predictions. This guide is educational and is not legal, tax, accounting, or investment advice.

  1. 1. Healthcare Services Quarterly Update, Q4 2025 (MNP). 8.5x average healthcare services EV/EBITDA in 2025; 6.0x for $10M to $25M deals (6.8x in 2024).
  2. 2. Home Health Valuation Multiples and M&A Trends 2025 (Scope Research). EBITDA multiple ranges by segment and size for personal care and home health.
  3. 3. Valuation Multiples from Small Home Health and Hospice M&A Transactions (Scope Research). 4.7x median EBITDA multiple (4.1x to 6.5x interquartile) for home-based deals under $10M EV.
  4. 4. FTC PE in Healthcare Workshop (FTC). Reference for the March 2024 government inquiry into healthcare ownership.

Reviewed September 2026

Questions owners ask

Straight answers, before you commit to anything.

What multiple will my agency get?+

Most independent agencies fall in published small-agency bands: about 3x to 5x adjusted EBITDA for personal care and 3x to 6x for Medicare-certified home health, with a 4.7x median for home-based care deals under $10 million of enterprise value (Scope Research). Where you land depends on your adjusted EBITDA, payer mix, and concentration profile, which is why we show you what actual buyers in our network say.

Do multiples change with interest rates?+

Yes. Acquisition financing costs affect what buyers can pay, particularly for leveraged platform deals. Demand for home care assets has remained strong across rate cycles because the underlying need keeps growing.

Is a strategic buyer always better than private equity?+

Not always. Strategics can pay for synergies but may absorb your brand and staff. Financial buyers often preserve the team and offer rollover equity. The right answer depends on what you want after closing.

Confidential inquiry

Tell us about your agency.

Everything you send stays between us. We never list or shop an agency, and nothing goes to a buyer without your explicit approval. There is no cost to you at any stage.